Skip to main content
Contact Us
Subscribe
E-Edition
90°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Oncternal Therapeutics Inc
(NQ:
ONCT
)
4.949
+0.099 (+2.04%)
Streaming Delayed Price
Updated: 3:48 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Oncternal Therapeutics Inc
< Previous
1
2
3
4
Next >
Looking Into Oncternal Therapeutics's Return On Capital Employed
May 18, 2023
Via
Benzinga
Oncternal Therapeutics: Q1 Earnings Insights
May 04, 2023
Via
Benzinga
NN And 2 Other Stocks Under $2 Insiders Are Aggressively Buying
April 18, 2023
The Dow Jones closed higher by over 100 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Why Kura Sushi Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
April 05, 2023
Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 104% to $5.55 after the company announced it has been selected by the U.S. Department of Defense for a position on the multiple award Indefinite...
Via
Benzinga
Oncternal Therapeutics's Return On Capital Employed Overview
March 14, 2023
Via
Benzinga
Oncternal Therapeutics's Earnings Outlook
March 08, 2023
Via
Benzinga
Oncternal Therapeutics's Return On Capital Employed Overview
November 24, 2022
Via
Benzinga
HC Wainwright Sees This Small-Cap Biotech As Undervalued, Underappreciated
June 13, 2022
Via
Benzinga
Why Chicken Soup For The Soul Entertainment Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
April 05, 2023
Gainers RiceBran Technologies (NASDAQ: RIBT) gained 43.1% to $1.33 in pre-market trading after gaining 3% on Tuesday.
Via
Benzinga
Oncternal Therapeutics Announces Strategic Reprioritization, Stops Two Zilovertamab Studies
April 04, 2023
Oncternal Therapeutics Inc (NASDAQ: ONCT) will suspend Phase 3 and the Phase 1/2 studies of zilovertamab in combination with ibrutinib, citing the rapidly changing commercial landscape for Bruton's...
Via
Benzinga
Dow Tumbles Over 200 Points; Butterfly Network Shares Spike Higher
April 04, 2023
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 200 points on Tuesday. The Dow traded down 0.64% to 33,387.61 while the NASDAQ fell 0.45% to 12,134.09. The S&P...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 04, 2023
Via
Benzinga
Why Bullfrog AI Holdings Shares Are Trading Higher By 73%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 04, 2023
Gainers Secoo Holding Limited (NASDAQ: SECO) shares surged 138% to $1.43.
Via
Benzinga
Why Is Nogin (NOGN) Stock Down 61% Today?
April 04, 2023
Nogin (NOGN) stock is falling hard on Tuesday after the company revealed details about a public offering for its shares.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 04, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2023
April 04, 2023
Via
Benzinga
Why Is Oncternal Therapeutics (ONCT) Stock Down 62% Today?
April 04, 2023
Oncternal Therapeutics (ONCT) stock is falling hard on Tuesday after the company decided to end two clinical trials to switch focus.
Via
InvestorPlace
Why AMC Entertainment Holdings Shares Are Trading Lower By 25%; Here Are 20 Stocks Moving Premarket
April 04, 2023
Gainers AMC Entertainment Hldg Pref Equity Units (NYSE: APE) gained 28.4% to $1.90 in pre-market trading. AMC Entertainment Holdings stated it agreed to settle litigation and move forward with...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
April 04, 2023
It's time to dive into the biggest pre-market stock movers for Tuesday morning with all the latest news traders need to know about!
Via
InvestorPlace
NVIDIA To Rally Over 22%? Here Are 10 Other Analyst Forecasts For Wednesday
March 22, 2023
Oppenheimer cut the price target for Oncternal Therapeutics, Inc. (NASDAQ: ONCT) from $14 to $9. Oppenheimer analyst Hartaj Singh maintained an Outperform rating. Oncternal Therapeutics shares fell...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 12, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2022
December 22, 2022
Via
Benzinga
Why JAKKS Pacific Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 10, 2023
Gainers Barnes & Noble Education, Inc. (NYSE: BNED) jumped 39% to $2.39 after the company posted better-than-expected quarterly sales.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
December 15, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
December 12, 2022
We're starting off the week with a look at the biggest pre-market stock movers traders need to know about for Monday morning!
Via
InvestorPlace
Recap: Oncternal Therapeutics Q2 Earnings
August 09, 2022
Oncternal Therapeutics (NASDAQ:ONCT) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:01 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Preview: Oncternal Therapeutics
August 08, 2022
Oncternal Therapeutics (NASDAQ:ONCT) is set to give its latest quarterly earnings report on Tuesday, 2022-08-09. Here's what investors need to know before the announcement.
Via
Benzinga
The Daily Biotech Pulse: FDA Signs Off Cancer Therapy Trials For NexImmune, Omega Therapeutics, Endo To Develop Rare Hereditary Skin Disease Candidate
July 15, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
June 10, 2022
Gainers bluebird bio (NASDAQ:BLUE) shares rose 53.4% to $6.12 during Friday's after-market session. Trading volume for this security closed at 5.0 million, accounting for 206.3% of its average full-day...
Via
Benzinga
44 Stocks Moving In Wednesday's Mid-Day Session
June 01, 2022
Gainers
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.